Fresenius Medical Care posts solid session with 1.39% gain; upside capped at $21.85

A quick look at yesterday: Fresenius Medical Care rallied 1.39% and ended the session at $21.83.

Fresenius Medical Care's uptick comes amid good United States macroeconomic data released during the day — data for United States Non Farm Payrolls published yesterday at 12:30 UTC came out at 339,000, beating projections of 180,000 and showing improvement over the preceding figure of 294,000.

Fresenius Medical Care's uptick comes amid disappointing United States macroeconomic data released during the session – highly important Average Hourly Earnings data from United States beat analyst expectations of 0.4% with a reading of 0.3%. Following a previous reading of 3.4, Unemployment Rate in United States released yesterday at 12:30 UTC fell short of the 3.5 figure expected by analysts with an actual reading of 3.7.

Fresenius Medical Care AG & Co. KGaA is currently trading around the $21.8 Fibonacci resistance level. Fresenius Medical Care's notable support and resistance levels: Fresenius Medical Care could be slowing down soon; it is getting close to the resistance line and is now at $21.89, only 6 cents away. Crossing the resistance line could, however, suggest that further gains are ahead.

This rally in Fresenius Medical Care's share price coincided with other health care stocks as AbbVie gained 2.57%, as it traded at $136.87. Novartis added 1.85% to its value, and traded at $98.91. Johnson & Johnson gained 1.57%, as it traded at $156.97.

The US-German healthcare company has managed to gain 36.18% so far this year despite trading at lows around $12.81 previously.